These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18320184)

  • 1. Use of ACE inhibitors and risk of community-acquired pneumonia: a review.
    Rafailidis PI; Matthaiou DK; Varbobitis I; Falagas ME
    Eur J Clin Pharmacol; 2008 Jun; 64(6):565-73. PubMed ID: 18320184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers decrease the risk of hospitalization secondary to community-acquired pneumonia? A nested case-control study.
    Etminan M; Zhang B; Fitzgerald M; Brophy JM
    Pharmacotherapy; 2006 Apr; 26(4):479-82. PubMed ID: 16553505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme insertion/deletion gene polymorphism in Egyptian children with CAP: A case-control study.
    Abouzeid H; Alkholy UM; Abdou MA; Morsy SM; Abdelrahman HM; Sherif AM; Abdalmonem N; Hamed ME; Allah MAN; Al Morshedy S; Elashkar SSA; Noah MA; Hegab MS; Akeel NE; Hashem MIA; Gawish HH; Fattah LA
    Pediatr Pulmonol; 2017 Dec; 52(12):1592-1598. PubMed ID: 29028160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of pneumonia risk by an angiotensin I-converting enzyme inhibitor in elderly Japanese inpatients according to insertion/deletion polymorphism of the angiotensin I-converting enzyme gene.
    Takahashi T; Morimoto S; Okaishi K; Kanda T; Nakahashi T; Okuro M; Murai H; Nishimura Y; Iwai K; Matsumoto M
    Am J Hypertens; 2005 Oct; 18(10):1353-9. PubMed ID: 16202861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of prior outpatient ACE inhibitor use on 30-day mortality for patients hospitalized with community-acquired pneumonia.
    Mortensen EM; Restrepo MI; Anzueto A; Pugh J
    BMC Pulm Med; 2005 Sep; 5():12. PubMed ID: 16159398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sources of heterogeneity in case-control studies on associations between statins, ACE-inhibitors, and proton pump inhibitors and risk of pneumonia.
    de Groot MC; Klungel OH; Leufkens HG; van Dijk L; Grobbee DE; van de Garde EM
    Eur J Epidemiol; 2014 Oct; 29(10):767-75. PubMed ID: 25154551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension.
    Li EC; Heran BS; Wright JM
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009096. PubMed ID: 25148386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme inhibitor use and pneumonia risk in a general population.
    van de Garde EM; Souverein PC; van den Bosch JM; Deneer VH; Leufkens HG
    Eur Respir J; 2006 Jun; 27(6):1217-22. PubMed ID: 16455828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme insertion/deletion polymorphism and risk and outcome of pneumonia.
    van de Garde EM; Endeman H; Deneer VH; Biesma DH; Sayed-Tabatabaei FA; Ruven HJ; Leufkens HG; van den Bosch JM
    Chest; 2008 Jan; 133(1):220-5. PubMed ID: 17908703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease.
    Sasongko TH; Nagalla S; Ballas SK
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD009191. PubMed ID: 26041152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of community-acquired pneumonia and the use of statins, ace inhibitors and gastric acid suppressants: a population-based case-control study.
    Myles PR; Hubbard RB; McKeever TM; Pogson Z; Smith CJ; Gibson JE
    Pharmacoepidemiol Drug Saf; 2009 Apr; 18(4):269-75. PubMed ID: 19235776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients With COVID-19 and Hypertension: A Single-Center Retrospective Study.
    Yang G; Tan Z; Zhou L; Yang M; Peng L; Liu J; Cai J; Yang R; Han J; Huang Y; He S
    Hypertension; 2020 Jul; 76(1):51-58. PubMed ID: 32348166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of hospitalization for community acquired pneumonia with renin-angiotensin blockade in elderly patients: a population-based study.
    Shah S; McArthur E; Farag A; Nartey M; Fleet JL; Knoll GA; Kim SJ; Garg AX; Jain AK
    PLoS One; 2014; 9(10):e110165. PubMed ID: 25353172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction. A meta-analysis of randomized clinical trials.
    Domanski MJ; Exner DV; Borkowf CB; Geller NL; Rosenberg Y; Pfeffer MA
    J Am Coll Cardiol; 1999 Mar; 33(3):598-604. PubMed ID: 10080457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease.
    Sasongko TH; Nagalla S; Ballas SK
    Cochrane Database Syst Rev; 2013 Mar; (3):CD009191. PubMed ID: 23543572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibitor use and pneumonia risk in community-dwelling older adults: results from a population-based case-control study.
    Dublin S; Walker RL; Jackson ML; Nelson JC; Weiss NS; Jackson LA
    Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1173-82. PubMed ID: 22949094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition.
    Harrap SB; Tzourio C; Cambien F; Poirier O; Raoux S; Chalmers J; Chapman N; Colman S; Leguennec S; MacMahon S; Neal B; Ohkubo T; Woodward M;
    Hypertension; 2003 Sep; 42(3):297-303. PubMed ID: 12925557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia.
    Mortensen EM; Pugh MJ; Copeland LA; Restrepo MI; Cornell JE; Anzueto A; Pugh JA
    Eur Respir J; 2008 Mar; 31(3):611-7. PubMed ID: 17959631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of serum angiotensin-converting enzyme activity for outcome of community-acquired pneumonia.
    Meijvis SC; Cornips MC; Endeman H; Ruven HJ; Danser AH; Biesma DH; Leufkens HG; Bos WJ; van de Garde EM
    Clin Chem Lab Med; 2011 Sep; 49(9):1525-32. PubMed ID: 21663571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of risk of pneumonia associated with use of angiotensin I converting enzyme inhibitors in elderly inpatients.
    Okaishi K; Morimoto S; Fukuo K; Niinobu T; Hata S; Onishi T; Ogihara T
    Am J Hypertens; 1999 Aug; 12(8 Pt 1):778-83. PubMed ID: 10480470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.